Kolltan
Arthur G. Altschul, Jr. is the Co-Founder of Kolltan and Chairman of Kolltan’s Board of Directors. Mr. Altschul has worked in money management, investment banking and as a member of senior management of a publicly-traded health care concern.
He is a founder of Diaz & Altschul Capital Management, LLC, a private investment advisory firm. Between 1985 and 1991, Mr. Altschul worked, variously, at Goldman, Sachs & Co., The Maximus Fund, LP and Morgan Stanley & Co.
From its founding in 1992 through 1996, Mr. Altschul worked at SUGEN, Inc., a biopharmaceutical company focused on cancer drug development, which was subsequently acquired by Pharmacia & Upjohn, Inc. Mr. Altschul is chairman of the board of directors of Medrium, Inc., a leader in medical transaction processing; he serves on the board of directors of General American Investors, Inc. (NYSE: GAM), a publicly-traded closed-end investment company with over $1 billion in gross assets and Medicis Pharmaceutical Corporation (NYSE: MRX), a specialty pharmaceutical company focused on the dermatology market.
He also is a director of the Delta Opportunity Fund, Ltd., and Diversified Natural Products, Inc. Mr. Altschul is a director of The Overbrook Foundation, and is a trustee of The Neurosciences Research Foundation, and the National Public Radio Foundation. Mr. Altschul received his B.Sc. in Computer Science from Columbia University.
